What Tata India Pharma & Healthcare Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Tata Mutual Fund.
Tata India Pharma & Healthcare Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| ABBOTT INDIA LTD | Added | +0.5% | 5.94% |
|---|---|---|---|
| DIVI LABORATORIES LTD | Reduced | −1.2% | 5.68% |
| APOLLO HOSPITALS ENTERPRISE LTD | Added | +6.2% | 4.36% |
| MAX HEALTHCARE INSTITUTE LTD | Added | +5.6% | 3.71% |
| TORRENT PHARMACEUTICALS LTD | Added | +3068.5% | 3.76% |
| FORTIS HEALTHCARE LTD | Reduced | −32.7% | 1.95% |
| BAYER CROPSCIENCE LTD | Added | +3.7% | 2.96% |
| MANKIND PHARMA LTD | Reduced | −75.5% | 0.77% |
| PROCTER & GAMBLE HEALTH LTD | Added | +9.7% | 2.75% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | Reduced | −70.2% | 0.76% |
| PI INDUSTRIES LTD | Added | +168.8% | 2.59% |
| ANTHEM BIOSCIENCES LTD | Added | +21.0% | 2.57% |
| FDC LTD | Added | +2.2% | 2.24% |
| ACUTAAS CHEMICALS LTD | Added | +22.3% | 1.95% |
| GLOBAL HEALTH LTD | Sold out | −100% | was 1.68% |
| ASTER DM QUALITY CARE LTD | Added | +9.9% | 1.67% |
| NATCO PHARMA LTD | New | New | 1.51% |
| MANIPAL HEALTH ENTERPRISES LTD | Reduced | −50.0% | 0.59% |
| GILLETTE INDIA LTD | Added | +14.2% | 1.23% |
| NAVIN FLUORINE INTERNATIONAL LTD | New | New | 1.18% |
| METROPOLIS HEALTHCARE LTD | Sold out | −100% | was 1.11% |
| BIOCON LTD | Reduced | −25.7% | 0.69% |
| PRASOL CHEMICALS LTD | New | New | 0.88% |
| MOLBIO DIAGNOSTICS LTD | Reduced | −50.7% | 0.54% |
| SYMBIOTEC PHARMALAB LTD | Added | +10.9% | 0.87% |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | Added | +15.0% | 0.57% |
| GUJARAT FLUOROCHEMICALS LTD | New | New | 0.53% |
| HDFC LIFE INSURANCE CO. LTD | Sold out | −100% | was 0.50% |
| JUBILANT PHARMOVA LTD | Reduced | −99.9% | 0.00% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did Tata India Pharma & Healthcare Fund buy in September 2026?
It bought 4 new stocks: NATCO PHARMA LTD (1.51%), NAVIN FLUORINE INTERNATIONAL LTD (1.18%), PRASOL CHEMICALS LTD (0.88%) and GUJARAT FLUOROCHEMICALS LTD (0.53%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did Tata India Pharma & Healthcare Fund sell completely in September 2026?
It sold all its shares in GLOBAL HEALTH LTD (1.68%), METROPOLIS HEALTHCARE LTD (1.11%) and HDFC LIFE INSURANCE CO. LTD (0.50%). Each figure is the stock's share of the fund at the end of August 2026.
Which stocks did Tata India Pharma & Healthcare Fund buy more of in September 2026?
The largest increases in shares held were TORRENT PHARMACEUTICALS LTD (+3068.5%), PI INDUSTRIES LTD (+168.8%), ACUTAAS CHEMICALS LTD (+22.3%), ANTHEM BIOSCIENCES LTD (+21.0%) and SANOFI CONSUMER HEALTHCARE INDIA LTD (+15.0%). It added to 9 more.
Which stocks did Tata India Pharma & Healthcare Fund sell part of in September 2026?
The largest cuts in shares held were JUBILANT PHARMOVA LTD (−99.9%), MANKIND PHARMA LTD (−75.5%), GLAXOSMITHKLINE PHARMACEUTICALS LTD (−70.2%), MOLBIO DIAGNOSTICS LTD (−50.7%) and MANIPAL HEALTH ENTERPRISES LTD (−50.0%). It reduced 3 more.
How are these changes worked out?
WealthGamma compares the number of shares Tata India Pharma & Healthcare Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Tata Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of Tata India Pharma & Healthcare Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.